Avista Public Acquisition Corp. II (AHPA) Shareholders Approve Ligand Deal
Avista Public Acquisition Corp. II (NASDAQ:AHPA) announced this afternoon that its shareholders have approved its combination with Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) to spin-off its antibody discovery business OmniAb, Inc. at a special meeting held earlier today. ...READ MORE
